Albor, Christian Dave .

HRN: 28-41-10  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2026
CEFTRIAXONE 1G (VIAL)
01/19/2026
02/02/2026
IV
1.5g
Q12
T/C Typhoid Fever
Checking Initial Appropriateness 
01/24/2026
MUPIROCIN 2%, 15G (TUBE)
01/24/2026
01/31/2026
TOPICAL
BID
BID
Skin Infection
Checking Initial Appropriateness 
01/30/2026
CEFTRIAXONE 1G (VIAL)
01/30/2026
02/06/2026
IV
1.5g
Q12h
T/C Typhoid Fever
Checking Initial Appropriateness 
01/31/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/31/2026
02/20/2026
IV
3.5g
Q6
T/C TB Meningitis
Checking Initial Appropriateness 
02/16/2026
CEFTRIAXONE 1G (VIAL)
02/16/2026
03/09/2026
IV
1g
Q12
Acute Bacterial Infection Of The Eye R
Checking Initial Appropriateness 
03/01/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/01/2026
03/07/2026
IV
1.7g
Q6H
TB Meningitis
Checking Initial Appropriateness 
03/04/2026
CEFTAZIDIME 1GM (VIAL)
03/04/2026
03/10/2026
IVT
35kg
Q8H
TB Meningitis, T/C New-onset Sepsis
Checking Initial Appropriateness 
03/04/2026
CEFTAZIDIME 1GM (VIAL)
03/04/2026
03/10/2026
IVT
1.7g
Q8H
TB Meningitis, T/C New-onset Sepsis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: